← Open Payments lookup

JEROME LASTIMOSA: Open Payments

NPI 1588316798 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$424 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $272 · 2025 $424

Food & beverage: $424
CompanyPaymentsAmount
Corcept Therapeutics5$126
Dexcom, Inc.1$114
Novo Nordisk Inc4$103
ABBVIE INC.1$25
Astellas Pharma US Inc1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
PFIZER INC.1$16

Products named: Korlym, DEXCOM G7 GSS (161), Wegovy, UBRELVY, Veozah, XIFAXAN, PAXLOVID.

Industry payments across MD — which companies pay providers there.